Radiotherapy and zoledronic acid for the treatment of kidney cancer bone metastases
Radiotherapy is often used for the treatment of bone metastases [...]
Patterns of initial metastatic recurrence after surgery for high-risk kidney cancer patients
This study looked at where metastases occurred after surgery for [...]
Bone metastases are associated with poor prognosis in papillary kidney cancer
A recent retrospective study looked at the data from 49 [...]
Bone-targeted therapies may improve survival in metastatic kidney cancer patients
A recent study published in the journal Translational Oncology suggests [...]
Effect of treatment delay on outcomes in metastatic kidney cancer
A recent study published in Science Direct followed patients with [...]
Prognosis of kidney cancer with bone metastases
A recent study, published in the European Journal of Cancer, [...]
Prognosis of kidney cancer patients with bone metastases
A recent study published in the European Journal of Cancer [...]
Rise factors for bone cancer
A study involving 45,824 patients newly diagnosed with renal cell [...]
An interdisciplinary consensus on the management of bone metastases from renal cell carcinoma
The International Kidney Cancer Coalition (IKCC), of which KCSN is [...]
Cabozantinib more effective than everolimus for treatment of kidney cancer bone metastases
Cabozantinib (Cabometyx) was more effective than everolimus (Afinitor) in people [...]
